# Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals

> **NCT04097925** · PHASE2 · COMPLETED · sponsor: **Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia** · enrollment: 30 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Doravirine
- **DRUG:** Descovy

## Key facts

- **NCT ID:** NCT04097925
- **Lead sponsor:** Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-18
- **Primary completion:** 2020-08-24
- **Final completion:** 2020-08-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04097925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04097925, "Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04097925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*